Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative 5-ALA Fluorescence Diagnosis in Meningioma Surgery
jRCTs031210158Completed
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in meningioma. Primary endpoint: Percentage of cases in which 5-ALA fluorescence allowed for additional tumor removal. Started Feb 2022; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
meningioma
Beyond the preview
Go deeper on jRCTs031210158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210158.